224 related articles for article (PubMed ID: 19667026)
21. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
Quan H; Zhang B; Lan Y; Luo X; Chen X
Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic/pharmacodynamic data extrapolation models for improved pediatric efficacy and toxicity estimation, with application to secondary hyperparathyroidism.
Basu C; Ma X; Mo M; Xia HA; Brundage R; Al-Kofahi M; Carlin BP
Pharm Stat; 2020 Nov; 19(6):882-896. PubMed ID: 32648333
[TBL] [Abstract][Full Text] [Related]
23. A scaled kernel density estimation prior for dynamic borrowing of historical information with application to clinical trial design.
Warren JL; Wang Q; Ciarleglio MM
Stat Med; 2024 Apr; 43(8):1615-1626. PubMed ID: 38345148
[TBL] [Abstract][Full Text] [Related]
24. Effect of grass sublingual tablet immunotherapy is similar in children and adults: A Bayesian approach to design pediatric sublingual immunotherapy trials.
Kaur A; Skoner D; Ibrahim J; Li Q; Lockey RF; Blaiss M; Bufe A; Andersen JS; Canonica GW; Nolte H
J Allergy Clin Immunol; 2018 May; 141(5):1744-1749. PubMed ID: 29221713
[TBL] [Abstract][Full Text] [Related]
25. Bayesian methods for the analysis of early-phase oncology basket trials with information borrowing across cancer types.
Jin J; Riviere MK; Luo X; Dong Y
Stat Med; 2020 Nov; 39(25):3459-3475. PubMed ID: 32717103
[TBL] [Abstract][Full Text] [Related]
26. Model-Based Assessment of Alternative Study Designs in Pediatric Trials. Part II: Bayesian Approaches.
Smania G; Baiardi P; Ceci A; Cella M; Magni P
CPT Pharmacometrics Syst Pharmacol; 2016 Aug; 5(8):402-10. PubMed ID: 27530374
[TBL] [Abstract][Full Text] [Related]
27. Handling Poor Accrual in Pediatric Trials: A Simulation Study Using a Bayesian Approach.
Azzolina D; Lorenzoni G; Bressan S; Da Dalt L; Baldi I; Gregori D
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33669985
[TBL] [Abstract][Full Text] [Related]
28. On the feasibility of pediatric dose-finding trials in small samples with information from a preceding trial in adults.
Zocholl D; Wiesenfarth M; Rauch G; Kopp-Schneider A
J Biopharm Stat; 2022 Sep; 32(5):652-670. PubMed ID: 34962850
[TBL] [Abstract][Full Text] [Related]
29. Bayesian design of noninferiority trials for medical devices using historical data.
Chen MH; Ibrahim JG; Lam P; Yu A; Zhang Y
Biometrics; 2011 Sep; 67(3):1163-70. PubMed ID: 21361889
[TBL] [Abstract][Full Text] [Related]
30. Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.
Lee SY
BMC Med Res Methodol; 2024 May; 24(1):110. PubMed ID: 38714936
[TBL] [Abstract][Full Text] [Related]
31. Bayesian sample size determination in basket trials borrowing information between subsets.
Zheng H; Grayling MJ; Mozgunov P; Jaki T; Wason JMS
Biostatistics; 2023 Oct; 24(4):1000-1016. PubMed ID: 35993875
[TBL] [Abstract][Full Text] [Related]
32. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
33. A frequentist approach to dynamic borrowing.
Li R; Lin R; Huang J; Tian L; Zhu J
Biom J; 2023 Oct; 65(7):e2100406. PubMed ID: 37189217
[TBL] [Abstract][Full Text] [Related]
34. PA-CRM: A continuous reassessment method for pediatric phase I oncology trials with concurrent adult trials.
Li Y; Yuan Y
Biometrics; 2020 Dec; 76(4):1364-1373. PubMed ID: 31950483
[TBL] [Abstract][Full Text] [Related]
35. Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses.
Zhang J; Lin R; Chen X; Yan F
Clin Trials; 2024 Jun; 21(3):308-321. PubMed ID: 38243401
[TBL] [Abstract][Full Text] [Related]
36. Variance prior specification for a basket trial design using Bayesian hierarchical modeling.
Cunanan KM; Iasonos A; Shen R; Gönen M
Clin Trials; 2019 Apr; 16(2):142-153. PubMed ID: 30526008
[TBL] [Abstract][Full Text] [Related]
37. A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barré syndrome.
Goodman SN; Sladky JT
Clin Trials; 2005; 2(4):305-10; discussion 364-78. PubMed ID: 16281429
[TBL] [Abstract][Full Text] [Related]
38. Perspectives on informative Bayesian methods in pediatrics.
Travis J; Rothmann M; Thomson A
J Biopharm Stat; 2023 Nov; 33(6):830-843. PubMed ID: 36710384
[TBL] [Abstract][Full Text] [Related]
39. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
Yu Q; Zhu L; Zhu H
Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
[TBL] [Abstract][Full Text] [Related]
40. Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.
Chen MH; Ibrahim JG; Zeng D; Hu K; Jia C
Biometrics; 2014 Dec; 70(4):1003-13. PubMed ID: 25041037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
